Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Tripepi

Showing results (171-180 of 517) with videos related to

Pageof 52
Sort By:
Journal of Nephrology|July 1, 2008
Coronary heart disease extension as a predictor of atherosclerotic renal artery stenosisBenedetta Stancanelli, Egle Maugeri, Antonino Nicosia, et al.
International Urology and Nephrology|May 10, 2023
Measures of frequency and effect in clinical researchGraziella D'Arrigo, Mercedes Gori, Annalisa Pitino, et al.
Journal of Nephrology|May 3, 2011
Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD)Giovanni Tripepi, Francesco Mattace-Raso, Patrizia Pizzini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2011
Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney diseaseGuido Grassi, Gino Seravalle, Lorenzo Ghiadoni, et al.
Clinical Kidney Journal|February 11, 2022
Translational research in nephrology: prognosisGiovanni Tripepi, Davide Bolignano, Kitty J Jager, et al.
Journal of Nephrology|February 25, 2015
Norepinephrine, left ventricular disorders and volume excess in ESRDSamar Abd ElHafeez, Giovanni Tripepi, Benedetta Stancanelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2018
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney diseaseClaudia Torino, Vincenzo Panuccio, Rocco Tripepi, et al.
Clinical Kidney Journal|August 26, 2024
Decoy receptors as biomarkers for exploring aetiology and designing new therapiesCarmine Zoccali, Giovanni Tripepi, Vianda Stel, et al.
Neurology|May 11, 2016
Long-term outcome of mild mesial temporal lobe epilepsy: A prospective longitudinal cohort studyAngelo Labate, Umberto Aguglia, Giovanni Tripepi, et al.
Kidney International Reports|September 11, 2018
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis PatientsClaudia Torino, Patrizia Pizzini, Sebastiano Cutrupi, et al.
Pageof 52

Showing results (171-180 of 517) with videos related to

Sort By:
Pageof 52
Journal of Nephrology|July 1, 2008
Coronary heart disease extension as a predictor of atherosclerotic renal artery stenosisBenedetta Stancanelli, Egle Maugeri, Antonino Nicosia, et al.
International Urology and Nephrology|May 10, 2023
Measures of frequency and effect in clinical researchGraziella D'Arrigo, Mercedes Gori, Annalisa Pitino, et al.
Journal of Nephrology|May 3, 2011
Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD)Giovanni Tripepi, Francesco Mattace-Raso, Patrizia Pizzini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2011
Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney diseaseGuido Grassi, Gino Seravalle, Lorenzo Ghiadoni, et al.
Clinical Kidney Journal|February 11, 2022
Translational research in nephrology: prognosisGiovanni Tripepi, Davide Bolignano, Kitty J Jager, et al.
Journal of Nephrology|February 25, 2015
Norepinephrine, left ventricular disorders and volume excess in ESRDSamar Abd ElHafeez, Giovanni Tripepi, Benedetta Stancanelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2018
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney diseaseClaudia Torino, Vincenzo Panuccio, Rocco Tripepi, et al.
Clinical Kidney Journal|August 26, 2024
Decoy receptors as biomarkers for exploring aetiology and designing new therapiesCarmine Zoccali, Giovanni Tripepi, Vianda Stel, et al.
Neurology|May 11, 2016
Long-term outcome of mild mesial temporal lobe epilepsy: A prospective longitudinal cohort studyAngelo Labate, Umberto Aguglia, Giovanni Tripepi, et al.
Kidney International Reports|September 11, 2018
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis PatientsClaudia Torino, Patrizia Pizzini, Sebastiano Cutrupi, et al.
Pageof 52